- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有256家主力机构披露2025-06-30报告期持股数据，持仓量总计2.29亿股，占流通A股54.94%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了42%的股票
技术面评分前10的股票
近期的平均成本为48.37元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为48.37元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"48.37","date":1760430999,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑赢行业平均水平。
[{"date":"2025.10.15","stock":"0.77","trade":"2.81","ind":"1.73"},{"date":"2025.10.14","stock":"-1.07","trade":"-1.72","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.95","trade":"-1.52","ind":"-0.93"},{"date":"2025.10.10","stock":"-0.96","trade":"-2.09","ind":"-2.70"},{"date":"2025.10.09","stock":"2.01","trade":"-0.06","ind":"1.47"},{"date":"2025.09.30","stock":"1.59","trade":"1.51","ind":"0.35"},{"date":"2025.09.29","stock":"-0.74","trade":"0.13","ind":"2.05"},{"date":"2025.09.26","stock":"-1.67","trade":"-2.13","ind":"-1.76"},{"date":"2025.09.25","stock":"-0.20","trade":"0.08","ind":"0.67"},{"date":"2025.09.24","stock":"1.55","trade":"1.51","ind":"1.80"},{"date":"2025.09.23","stock":"-2.96","trade":"-3.08","ind":"-0.29"},{"date":"2025.09.22","stock":"-0.55","trade":"-0.10","ind":"0.67"},{"date":"2025.09.19","stock":"-0.71","trade":"-1.53","ind":"-0.04"},{"date":"2025.09.18","stock":"-1.43","trade":"-1.87","ind":"-1.06"},{"date":"2025.09.17","stock":"-1.26","trade":"-0.79","ind":"1.16"},{"date":"2025.09.16","stock":"-1.41","trade":"1.18","ind":"0.45"},{"date":"2025.09.15","stock":"-3.11","trade":"1.00","ind":"0.63"},{"date":"2025.09.12","stock":"5.84","trade":"1.42","ind":"-0.43"},{"date":"2025.09.11","stock":"1.83","trade":"-0.05","ind":"3.36"},{"date":"2025.09.10","stock":"-2.17","trade":"1.48","ind":"0.38"},{"date":"2025.09.09","stock":"-2.03","trade":"-2.41","ind":"-1.23"}]
华大基因,深证成指,医疗服务指数
压力支撑
该股压力位为48.17元，支撑位为47.62元。
[{"text":"\u538b\u529b\u4f4d","value":"48.17","date":1760457600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"47.62","date":1760457600,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了16%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：10月15日 17:59
| 机构今日流向(万元) | 2580.13 | 机构5日流向(万元) | -9350.09 |
| 机构10日流向(万元) | -7167.12 | 机构20日流向(万元) | -28135.61 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少677.53万股，其中基金净减仓83家，主力净增仓79家，暂未发现中长期投资价值。
截止2025-06-30，共256家主力机构（基金251家，一般法人4家，QFII1家），持仓量总计22855.57万股，占流通A股54.94%
其中，基金持仓与2024-12-31相比：
增仓：24家 ，增持 59.05万股
减仓：107家 ，减持 754.41万股
新出现在主力名单中：109家 ，持有1366.88万股
从主力名单中消失：30家 ，原持有549.22万股
其中，基金持仓与2024-12-31相比：
增仓：24家 ，增持 59.05万股
减仓：107家 ，减持 754.41万股
新出现在主力名单中：109家 ，持有1366.88万股
从主力名单中消失：30家 ，原持有549.22万股
消息面诊股
诊断结果：5.5消息面打败了35%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 2025年中国蛋白质组学科研服务行业产业链、市场规
2025-10-15 - 华大基因：10月14日持仓该股ETF资金净流出57
2025-10-15 - AI医疗+智能硬件，产业链分布与代表企业（附名单）
2025-10-14 - 华大基因：10月13日获融资买入3760.56万元
2025-10-14 - 华大基因：10月10日持仓该股ETF资金净流入54
2025-10-13 - 华大基因：10月10日获融资买入2777.22万元
2025-10-13 - 生物制造剑指万亿元台阶，广东将再推重磅政策“对症下
2025-10-12 - 华大基因：10月9日获融资买入7502.18万元
2025-10-10 - 600382，预增上限超10倍！脑机接口，利好来了
2025-10-10 - 东湖高新区支持脑机接口关键技术研发 多只脑机接口概
2025-10-10
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-30 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-09-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-20 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-07-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-26 |
| 一般消息 | 募资投向 | 2025-04-27 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-03 |
| 一般消息 | 重大事项 | 关联交易 | 2025-02-11 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-01-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-24 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-14 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-30 |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-11-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：1.9行业面打败了22%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.10.15","price":"1.73","value":"2.81"},{"date":"2025.10.14","price":"-2.54","value":"-1.72"},{"date":"2025.10.13","price":"-0.93","value":"-1.52"},{"date":"2025.10.10","price":"-2.70","value":"-2.09"},{"date":"2025.10.09","price":"1.47","value":"-0.06"},{"date":"2025.09.30","price":"0.35","value":"1.51"},{"date":"2025.09.29","price":"2.05","value":"0.13"},{"date":"2025.09.26","price":"-1.76","value":"-2.13"},{"date":"2025.09.25","price":"0.67","value":"0.08"},{"date":"2025.09.24","price":"1.80","value":"1.51"},{"date":"2025.09.23","price":"-0.29","value":"-3.08"},{"date":"2025.09.22","price":"0.67","value":"-0.10"},{"date":"2025.09.19","price":"-0.04","value":"-1.53"},{"date":"2025.09.18","price":"-1.06","value":"-1.87"},{"date":"2025.09.17","price":"1.16","value":"-0.79"},{"date":"2025.09.16","price":"0.45","value":"1.18"},{"date":"2025.09.15","price":"0.63","value":"1.00"},{"date":"2025.09.12","price":"-0.43","value":"1.42"},{"date":"2025.09.11","price":"3.36","value":"-0.05"},{"date":"2025.09.10","price":"0.38","value":"1.48"},{"date":"2025.09.09","price":"-1.23","value":"-2.41"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 诚达药业 | 15.57% | -1.47% | 5.6分 |
| 2 | 皓元医药 | 14.08% | -6.54% | 6.0分 |
| 3 | 奥浦迈 | 13.67% | -10.14% | 6.2分 |
| 4 | 益诺思 | 13.42% | -9.17% | 5.4分 |
| 5 | 九洲药业 | 10.09% | 6.58% | 6.7分 |
| 6 | 毕得医药 | 9.43% | -10.97% | 4.9分 |
| 8 | 三博脑科 | 5.88% | 5.97% | 6.1分 |
| 10 | 昭衍新药 | 3.41% | -5.61% | 5.2分 |
| 12 | 和元生物 | 1.42% | -0.51% | 5.7分 |
| 14 | 博腾股份 | -0.20% | -3.76% | 5.2分 |
| 16 | 光正眼科 | -0.46% | 2.11% | 6.7分 |
| 18 | 爱尔眼科 | -1.48% | 2.76% | 6.8分 |
| 20 | 普瑞眼科 | -2.45% | 1.23% | 5.2分 |
| 22 | 金凯生科 | -3.59% | 0.22% | 5.5分 |
| 24 | ST中珠 | -4.15% | -3.65% | 4.8分 |
| 26 | 万邦医药 | -4.49% | -0.72% | 5.6分 |
| 28 | 兰卫医学 | -5.70% | -0.43% | 5.7分 |
| 30 | 药石科技 | -6.16% | -2.15% | 5.2分 |
| 32 | 博济医药 | -6.34% | -1.10% | 5.0分 |
| 34 | 通策医疗 | -6.98% | -0.48% | 5.9分 |
| 36 | 普蕊斯 | -7.99% | -8.49% | 5.0分 |
| 38 | 成都先导 | -8.95% | -7.26% | 5.5分 |
| 40 | 迪安诊断 | -9.50% | -4.58% | 5.8分 |
| 42 | 盈康生命 | -10.31% | -2.45% | 6.2分 |
| 44 | 睿智医药 | -10.88% | 2.63% | 5.4分 |
| 46 | 药康生物 | -14.30% | -9.41% | 6.1分 |
| 48 | 泰格医药 | -14.83% | -5.05% | 5.2分 |
| 50 | 海特生物 | -17.03% | 0.97% | 4.5分 |
| 52 | - | -20.92% | -8.73% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 39/101 ， 15/101。
[{"date":"2025-06-30","value":"0.06","vol":"2.23"},{"date":"2025-03-31","value":"-0.58","vol":"0.92"},{"date":"2024-12-31","value":"-9.51","vol":"-0.15"},{"date":"2024-09-30","value":"-1.26","vol":"3.24"},{"date":"2024-06-30","value":"0.18","vol":"2.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.06 | -0.58 | -9.51 | -1.26 | 0.18 |
| 行业(%) | 2.23 | 0.92 | -0.15 | 3.24 | 2.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"44.65","vol":"36.06"},{"date":"2025-03-31","value":"43.55","vol":"34.67"},{"date":"2024-12-31","value":"41.47","vol":"34.77"},{"date":"2024-09-30","value":"45.22","vol":"36.16"},{"date":"2024-06-30","value":"47.23","vol":"36.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
44.65 | 43.55 | 41.47 | 45.22 | 47.23 |
| 行业(%) | 36.06 | 34.67 | 34.77 | 36.16 | 36.37 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 41/101 ， 43/101。
[{"date":"2025-06-30","value":"-12.82","vol":"2.42"},{"date":"2025-03-31","value":"-18.18","vol":"-0.08"},{"date":"2024-12-31","value":"-11.10","vol":"-0.73"},{"date":"2024-09-30","value":"-10.10","vol":"0.87"},{"date":"2024-06-30","value":"-9.67","vol":"0.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-12.82 | -18.18 | -11.10 | -10.10 | -9.67 |
| 行业(%) | 2.42 | -0.08 | -0.73 | 0.87 | 0.65 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-68.25","vol":"-71.46"},{"date":"2025-03-31","value":"-524.87","vol":"-25.93"},{"date":"2024-12-31","value":"-1071.68","vol":"-96.53"},{"date":"2024-09-30","value":"-276.49","vol":"-161.08"},{"date":"2024-06-30","value":"-63.45","vol":"-107.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-68.25 | -524.87 | -1071.68 | -276.49 | -63.45 |
| 行业(%) | -71.46 | -25.93 | -96.53 | -161.08 | -107.95 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 41/101 ， 34/101。
[{"date":"2025-06-30","value":"0.13","vol":"0.20"},{"date":"2025-03-31","value":"0.05","vol":"0.10"},{"date":"2024-12-31","value":"0.30","vol":"0.41"},{"date":"2024-09-30","value":"0.21","vol":"0.31"},{"date":"2024-06-30","value":"0.14","vol":"0.20"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.05 | 0.30 | 0.21 | 0.14 |
| 行业(次) | 0.20 | 0.10 | 0.41 | 0.31 | 0.20 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.55","vol":"7.41"},{"date":"2025-03-31","value":"0.65","vol":"3.76"},{"date":"2024-12-31","value":"3.76","vol":"16.35"},{"date":"2024-09-30","value":"2.35","vol":"14.25"},{"date":"2024-06-30","value":"1.64","vol":"8.86"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.55 | 0.65 | 3.76 | 2.35 | 1.64 |
| 行业(次) | 7.41 | 3.76 | 16.35 | 14.25 | 8.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 45/101 ， 34/101。
[{"date":"2025-06-30","value":"-1.75","vol":"15.87"},{"date":"2025-03-31","value":"-59.10","vol":"-1.69"},{"date":"2024-12-31","value":"22.91","vol":"22.34"},{"date":"2024-09-30","value":"-6.53","vol":"12.23"},{"date":"2024-06-30","value":"-0.43","vol":"9.92"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -1.75 | -59.10 | 22.91 | -6.53 | -0.43 |
| 行业 | 15.87 | -1.69 | 22.34 | 12.23 | 9.92 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.97","vol":"0.94"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.97","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.73","vol":"1.44"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.97 | - | 0.97 | - | 0.73 |
| 行业 | 0.94 | 0.00 | 1.31 | 0.00 | 1.44 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/101 ， 34/101。
[{"date":"2025-06-30","value":"2.81","vol":"3.69"},{"date":"2025-03-31","value":"2.85","vol":"3.84"},{"date":"2024-12-31","value":"2.42","vol":"3.70"},{"date":"2024-09-30","value":"2.63","vol":"4.11"},{"date":"2024-06-30","value":"2.74","vol":"4.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.81 | 2.85 | 2.42 | 2.63 | 2.74 |
| 行业 | 3.69 | 3.84 | 3.70 | 4.11 | 4.14 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.49","vol":"2.98"},{"date":"2025-03-31","value":"2.52","vol":"3.12"},{"date":"2024-12-31","value":"2.13","vol":"3.01"},{"date":"2024-09-30","value":"2.30","vol":"3.38"},{"date":"2024-06-30","value":"2.41","vol":"3.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.49 | 2.52 | 2.13 | 2.30 | 2.41 |
| 行业 | 2.98 | 3.12 | 3.01 | 3.38 | 3.39 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/101 ， 33/101。
[{"date":"2025-06-30","value":"24.81","vol":"32.65"},{"date":"2025-03-31","value":"26.68","vol":"32.24"},{"date":"2024-12-31","value":"26.08","vol":"32.31"},{"date":"2024-09-30","value":"24.94","vol":"31.03"},{"date":"2024-06-30","value":"23.88","vol":"31.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
24.81 | 26.68 | 26.08 | 24.94 | 23.88 |
| 行业(%) | 32.65 | 32.24 | 32.31 | 31.03 | 31.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.33","vol":"0.95"},{"date":"2025-03-31","value":"0.37","vol":"0.98"},{"date":"2024-12-31","value":"0.36","vol":"1.01"},{"date":"2024-09-30","value":"0.34","vol":"0.85"},{"date":"2024-06-30","value":"0.32","vol":"0.87"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.33 | 0.37 | 0.36 | 0.34 | 0.32 |
| 行业(%) | 0.95 | 0.98 | 1.01 | 0.85 | 0.87 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"14.62","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.93","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-9.03","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.25","blueLineValue":"0.06","type":"YC"}]